Growth Metrics

Amneal Pharmaceuticals (AMRX) Cash from Restructuring (2019 - 2020)

Amneal Pharmaceuticals (AMRX) has 2 years of Cash from Restructuring data on record, last reported at -$536000.0 in Q3 2020.